Oppenheimer raises UroGen Pharma stock price target to $50 on sales outlook

Markets Investing.com By Investing.com 16 Jul 2026 11:44 1 min read

Oppenheimer raises UroGen Pharma stock price target to $50 on sales outlook

Oppenheimer raises UroGen Pharma stock price target to $50 on sales outlook

Oppenheimer raises UroGen Pharma stock price target to $50 on sales outlook

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.